Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Mimedx (MDXG) Receivables - Net (2016 - 2025)

Mimedx (MDXG) has disclosed Receivables - Net for 15 consecutive years, with $75.7 million as the latest value for Q4 2025.

  • Quarterly Receivables - Net rose 35.61% to $75.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $75.7 million through Dec 2025, up 35.61% year-over-year, with the annual reading at $75.7 million for FY2025, 35.61% up from the prior year.
  • Receivables - Net hit $75.7 million in Q4 2025 for Mimedx, down from $83.6 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $83.6 million in Q3 2025 to a low of $35.4 million in Q1 2021.
  • Historically, Receivables - Net has averaged $51.4 million across 5 years, with a median of $51.4 million in 2023.
  • Biggest five-year swings in Receivables - Net: increased 1.12% in 2022 and later surged 54.73% in 2025.
  • Year by year, Receivables - Net stood at $40.4 million in 2021, then increased by 6.77% to $43.1 million in 2022, then grew by 25.04% to $53.9 million in 2023, then grew by 3.63% to $55.8 million in 2024, then surged by 35.61% to $75.7 million in 2025.
  • Business Quant data shows Receivables - Net for MDXG at $75.7 million in Q4 2025, $83.6 million in Q3 2025, and $73.2 million in Q2 2025.